Efficacy and safety of sertindole in schizophrenia: a clinical review

Sertindole is an atypical antipsychotic reintroduced into the European market in 2005 after a reevaluation of its risks and benefits, under the agreement that close electrocardiographic screening would be conducted. It has a high affinity for dopamine D2, serotonin 5-HT2A and 5-HT2C, and α1 adrenerg...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical psychopharmacology 2015-06, Vol.35 (3), p.286-295
Hauptverfasser:	Zoccali, Rocco A, Bruno, Antonio, Muscatello, Maria Rosaria Anna
Format:	Artikel
Sprache:	eng
Schlagworte:	Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Humans Imidazoles - adverse effects Imidazoles - therapeutic use Indoles - adverse effects Indoles - therapeutic use Schizophrenia - drug therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!